{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/innovative-ocular-solutions-improving-lives-through-advanced-therapies-0#webpage",
"url": "https://www.fortrea.com/insights/innovative-ocular-solutions-improving-lives-through-advanced-therapies-0",
"name": "Innovative ocular solutions: Improving lives through advanced therapies",
"description": "Explore this Fortrea Info Sheet highlighting the company's expertise in advanced ocular therapies and specialized ophthalmology clinical development. Drawing on more than three decades of CRO experience and extensive ophthalmology capabilities, Fortrea supports sponsors developing innovative treatments across front- and back-of-the-eye indications, rare ocular diseases, ophthalmic devices, diagnostics, pediatric ophthalmology programs, and emerging ocular cell and gene therapies. The resource showcases Fortrea's experience conducting global ophthalmology clinical trials and emphasizes a patient-centric approach designed to reduce burden on patients, caregivers, and investigative sites while maintaining high-quality data and patient safety standards. It highlights the importance of scientific, operational, and regulatory expertise in navigating the complexities of ophthalmology research, from early development through commercialization. The information also outlines comprehensive support services including study design consultation, protocol development, site and patient support, regulatory guidance, laboratory oversight, global logistics, vendor management, and trial execution strategies tailored to ophthalmology programs. By combining therapeutic expertise, global operational capabilities, and collaborative partnerships, Fortrea helps sponsors advance advanced ocular therapies, optimize study delivery, and support the development of innovative treatments for patients living with vision-threatening and rare eye diseases worldwide."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Innovative ocular solutions: Improving lives through advanced therapies",
"item": "https://www.fortrea.com/insights/innovative-ocular-solutions-improving-lives-through-advanced-therapies-0"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/innovative-ocular-solutions-improving-lives-through-advanced-therapies-0#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/innovative-ocular-solutions-improving-lives-through-advanced-therapies-0#webpage"
},
"headline": "Advancing Ocular Therapies Through Specialized Ophthalmology Clinical Development | Fortrea Info Sheet",
"description": "Explore this Fortrea Info Sheet highlighting the company's expertise in advanced ocular therapies and specialized ophthalmology clinical development. Drawing on more than three decades of CRO experience and extensive ophthalmology capabilities, Fortrea supports sponsors developing innovative treatments across front- and back-of-the-eye indications, rare ocular diseases, ophthalmic devices, diagnostics, pediatric ophthalmology programs, and emerging ocular cell and gene therapies. The resource showcases Fortrea's experience conducting global ophthalmology clinical trials and emphasizes a patient-centric approach designed to reduce burden on patients, caregivers, and investigative sites while maintaining high-quality data and patient safety standards. It highlights the importance of scientific, operational, and regulatory expertise in navigating the complexities of ophthalmology research, from early development through commercialization. The information also outlines comprehensive support services including study design consultation, protocol development, site and patient support, regulatory guidance, laboratory oversight, global logistics, vendor management, and trial execution strategies tailored to ophthalmology programs. By combining therapeutic expertise, global operational capabilities, and collaborative partnerships, Fortrea helps sponsors advance advanced ocular therapies, optimize study delivery, and support the development of innovative treatments for patients living with vision-threatening and rare eye diseases worldwide.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2026-04/innovative-ocular-solutions.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-04-23",
"dateModified": "2026-04-23",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/advanced-ocular-therapies.pdf",
"encodingFormat": "application/pdf"
}
}
]
}